| Targeting TBK1 to overcome resistance to cancer immunotherapy Y Sun, O Revach, S Anderson, EA Kessler, CH Wolfe, A Jenney, CE Mills, ... Nature 615 (7950), 158-167, 2023 | 87 | 2023 |
| Validation and characterization of a novel method for selective vagal deafferentation of the gut C Diepenbroek, D Quinn, R Stephens, B Zollinger, S Anderson, A Pan, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 313 (4 …, 2017 | 67 | 2017 |
| Blunted vagal cocaine-and amphetamine-regulated transcript promotes hyperphagia and weight gain SJ Lee, JP Krieger, M Vergara, D Quinn, M McDougle, A de Araujo, ... Cell reports 30 (6), 2028-2039. e4, 2020 | 42 | 2020 |
| Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy OY Revach, AM Cicerchia, O Shorer, B Petrova, S Anderson, J Park, ... bioRxiv, 2024 | 4 | 2024 |
| Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint HW Tsao, S Anderson, KJ Finn, JJ Perera, LF Pass, EM Schneider, ... Immunity 57 (12), 2863-2878. e12, 2024 | | 2024 |
| In vivo gain-of-function screen identifies CREB5, a novel ECM modulator that promotes immunotherapy resistance via the Collagen-Lair1 axis P Tiwari, K Colvin, S Kim, A Kammula, S Anderson, OY Revach, M Vyas, ... CANCER IMMUNOLOGY RESEARCH 11 (12), 2023 | | 2023 |
| Abstract B021: In vivo gain-of-function screen identifies CREB5, a novel ECM modulator that promotes immunotherapy resistance via the Collagen-Lair1 axis P Tiwari, K Colvin, S Kim, A Kammula, S Anderson, OY Revach, M Vyas, ... Cancer Immunology Research 11 (12_Supplement), B021-B021, 2023 | | 2023 |
| 561 Targeting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy OY Revach, A Cicerchia, M Sade-Feldman, S Anderson, B Petrova, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Cigarette Smoke Activates the Angiogenic Switch in the Lung Cancer Field by Downregulating MicroRNA-1 A Korde, A Ramaswamy, S Anderson, B Hu, W Velasco Torrez, MA Pisani, ... D31. IMAGING, BIOMARKERS, AND MACHINE LEARNING IN LUNG CANCER, A6530-A6530, 2023 | | 2023 |
| Targeting CD38 on exhausted T cells overcomes resistance to cancer immunotherapy OY Revach, AM Cicerchia, M Sade-Feldman, S Anderson, RT Manguso, ... Cancer Research 83 (7_Supplement), 3250-3250, 2023 | | 2023 |
| Abstract 3285: Targeting TBK1 to overcome resistance to cancer immunotherapy RWJ Yi Sun, Or-Yam Revach, Seth Anderson, Anne Jenney, Caitlin E. Mills ... Cancer Research 83 (7_Supplement), 3285, 2023 | | 2023 |
| Abstract B28: Targeting TBK1 to overcome resistance to cancer immunotherapy Y Sun, O Revach, S Anderson, RT Manguso, RW Jenkins Cancer Immunology Research 10 (12_Supplement), B28-B28, 2022 | | 2022 |
| Gram Negative Infection Accelerates Lung Endothelial Cell Death Through Regulation of MicroRNA-1/Angiopoietin-2 Pathway A Korde, S Anderson, M Haslip, S Takyar A60. LUNG INJURY, SEPSIS, AND ARDS, A2072-A2072, 2019 | | 2019 |
| Cigarette Smoke Activates PI3 Kinase Pathway and Downregulates MicroRNA-1 in Non-Small Cell Lung Cancer (NSCLC) A Korde, A Ramaswami, MS Godfrey, S Anderson, S Takyar B68. ONCOGENIC MUTATIONS, METASTASIS, AND NOVEL THERAPEUTICS, A3961-A3961, 2019 | | 2019 |